MJP Associates’s BlueLinx BXC Stock Holding History

MJP Associates’s Portfolio BXC Stock Details BXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,937	Closed	-$446K	–	231
2023 Q4	$446K	Buy	+3,937	New	+$341K	0.12%	85

Other funds holding BXC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GJL

Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return

JCP

JB Capital Partners Armonk, New York $581M AUM 46.16% 1-Year Est. Return

PAIM

Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MJP Associates's BXC Position: Q1 2024 in Review

MJP Associates sold out of BlueLinx (BXC) in Q1 2024, closing a stake of 3,937 shares — an estimated $446K sold.

MJP Associates first reported a position in BXC in Q4 2023 and held it in 1 quarter. The position peaked at $446K in Q4 2023. 181 funds tracked by Wall St. Rank hold BXC as of Q1 2024.

MJP Associates reported no remaining BlueLinx position as of Q1 2024 after selling out during the quarter.
MJP Associates sold 3,937 BlueLinx shares in Q1 2024, an estimated $446K.
MJP Associates first reported a position in BlueLinx in Q4 2023 and held it in 1 quarter.
MJP Associates's BlueLinx position peaked at $446K in Q4 2023.
181 funds tracked by Wall St. Rank held BlueLinx as of Q1 2024.

Based on MJP Associates's 13F filing for Q1 2024, filed 11 Apr 2024.